from a poster on another board with a long history of sensible postings that are not full of **** Send the CYT mobsters and 1.10'ers packing Oh and you get the risk/upside with ATC
Vote FOR the Merger and Buyback
From MSS on other board
Suppose:
Pi-88 "failed" on every ph ii trial, but liver cancer. The failures drove the market value of PI-88 down. With a superior product establishing dominance in liver cancer, Pi-88's market value spiraled even further downward.
Along with the crashing market value for Pi-88, liver cancer patients opted for an easier to swallow therapy after service providers pointed it out to them as an option, impeding timely clinical testing of Pi-88 for liver cancer.
If so, the BOD made the tough call and the right call on Pi-88. Like everyone else, I did not want to hear the BOD's message. I wanted to blame the messenger rather than the simple hard nosed truth.
Since the elements that affirm this storyline are straightforward and transparent, I happen to believe the BOD did its job in good faith, which is not to say they did it without a few public relations gaffes, which is not the same thing as malfeasance or subverting Pi-88 for their own selfish ends.
The Moses group came to plunder the treasury and were rejected. Now, CYT is willing to serve as the frontman for a bunch of institutional thieves under the mask of merging oncology therapies and returning "shareholders" their money, if they wish. While theft may seem a bit over the top, CYT's intent is one of two, and each leads to a pilfering of Progen's coffers. In one scenario for using the remaining Progen capital for a buy out of CYT and limiting the Progen's capital resources to develop any other Progen therapy. CYT shareholders get a share price increase while the idiots who do not cash out of Progen get to bend over for the big one from the boys from CYT. In another scenario for using the remaining capital of Progen to buy an equity, but not majority, stake in CYT. Again, a premium for CYT shareholders and a shaft job for the remaining Progen shareholders.
Vote for the AVX merger. Send the CYT mobsters packing.
It's that simple.
GLTA
PGL Price at posting:
72.3¢ Sentiment: LT Buy Disclosure: Held